PT1996710T - Preparação da disfunção anti-rectal de rifaximina. - Google Patents
Preparação da disfunção anti-rectal de rifaximina.Info
- Publication number
- PT1996710T PT1996710T PT77525384T PT07752538T PT1996710T PT 1996710 T PT1996710 T PT 1996710T PT 77525384 T PT77525384 T PT 77525384T PT 07752538 T PT07752538 T PT 07752538T PT 1996710 T PT1996710 T PT 1996710T
- Authority
- PT
- Portugal
- Prior art keywords
- rectal dysfunction
- rifaximin anti
- dysfunction preparation
- preparation
- rifaximin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78114406P | 2006-03-09 | 2006-03-09 | |
| US79123606P | 2006-04-11 | 2006-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1996710T true PT1996710T (pt) | 2019-10-25 |
Family
ID=38475539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT77525384T PT1996710T (pt) | 2006-03-09 | 2007-03-06 | Preparação da disfunção anti-rectal de rifaximina. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8987292B2 (pt) |
| EP (1) | EP1996710B1 (pt) |
| JP (2) | JP5331487B2 (pt) |
| KR (1) | KR101398648B1 (pt) |
| CN (2) | CN101594885B (pt) |
| AU (1) | AU2007223881B2 (pt) |
| BR (1) | BRPI0708561A2 (pt) |
| CA (1) | CA2643364C (pt) |
| DK (1) | DK1996710T3 (pt) |
| ES (1) | ES2747259T3 (pt) |
| MX (1) | MX2008011305A (pt) |
| PT (1) | PT1996710T (pt) |
| WO (1) | WO2007103448A2 (pt) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040018237A1 (en) * | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| SI2294012T1 (sl) * | 2008-05-07 | 2014-11-28 | Salix Pharmaceuticals, Ltd. | Dajanje ÄŤistila za ÄŤrevo in antibiotika za zdravljenje ÄŤrevesne bolezni |
| RU2011116400A (ru) * | 2008-09-26 | 2012-11-10 | Аска Фармасьютикал Ко., Лтд. (Jp) | Средство для предотвращения и/или лечения функционального расстройства желудочно-кишечного тракта |
| US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
| US20100204173A1 (en) | 2008-10-02 | 2010-08-12 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
| CA2765033C (en) | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| WO2011061519A2 (en) | 2009-11-23 | 2011-05-26 | Cipla Limited | Topical foam composition |
| RU2012126080A (ru) * | 2009-11-23 | 2013-12-27 | Сипла Лимитед | Местная пенообразующая композиция |
| US20130315998A1 (en) * | 2009-11-23 | 2013-11-28 | Cipla Limited | Topical Foam Composition |
| GB201012410D0 (en) | 2010-07-23 | 2010-09-08 | Medical Res Council | Intracellular immunity |
| WO2012076832A1 (en) * | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
| JP2014508166A (ja) | 2011-03-17 | 2014-04-03 | トランスダーマル バイオテクノロジ インコーポレーテッド | 局所的一酸化窒素システム及びその使用方法 |
| CN102512358B (zh) * | 2011-12-16 | 2013-04-10 | 南京农业大学 | 家畜用利福昔明阴道栓剂及其制备方法 |
| RU2483721C1 (ru) * | 2012-05-17 | 2013-06-10 | Общество с ограниченной ответственностью "Общество лабораторных исследований медицинских препаратов" | Лекарственная композиция на основе тизоля для лечения анальных трещин |
| US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
| US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
| US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
| US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
| US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
| US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
| US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| WO2016003536A1 (en) * | 2014-06-30 | 2016-01-07 | Salix Pharmaceuticals, Inc. | Methods for retreating irritable bowel syndrome (ibs) |
| CN104083324B (zh) * | 2014-07-10 | 2017-05-10 | 青岛动保国家工程技术研究中心有限公司 | 一种利福昔明的兽用悬乳剂及其制备方法和应用 |
| US20180171389A1 (en) * | 2015-06-16 | 2018-06-21 | Murdoch Childrens Research Institute | Method of treating crohn's disease |
| WO2017137489A1 (en) * | 2016-02-12 | 2017-08-17 | Dsm Ip Assets B.V. | Anti-methanogenic compositions and uses thereof |
| KR20210011693A (ko) | 2019-07-23 | 2021-02-02 | 주식회사 대웅테라퓨틱스 | 리팍시민 및 디옥타헤드랄 스멕타이트를 포함하는 염증성 장 질환 예방 및 치료용 조성물 |
| KR20210011692A (ko) | 2019-07-23 | 2021-02-02 | 주식회사 대웅테라퓨틱스 | 리팍시민 및 니클로사마이드를 포함하는 염증성 장 질환 예방 및 치료용 조성물 |
| US20220378758A1 (en) * | 2019-09-24 | 2022-12-01 | Bausch Health Ireland Limited | Rifaximin liquid formulations |
| WO2023039276A1 (en) * | 2021-09-13 | 2023-03-16 | Curtails Llc | Use of ibat inhibitors and antimicrobials for the treatment of diseases |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2907118A1 (de) | 1979-02-20 | 1980-09-04 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| IT1199374B (it) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
| PT1051972E (pt) * | 1994-05-27 | 2007-12-07 | Strakan Internat Ltd Uma Socie | Composição dadora de óxido nítrico para tratamento de distúrbios anais |
| US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
| WO2001043735A1 (en) * | 1999-12-15 | 2001-06-21 | Cellegy Pharmaceuticals, Inc. | Nitroglycerin ointment for treatment of pain associated with anal disease |
| IL154537A0 (en) * | 2000-08-29 | 2003-09-17 | Nobex Corp | 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| ES2687039T3 (es) * | 2004-03-23 | 2018-10-23 | Biocon Limited | Métodos y composiciones que emplean compuestos de ácido 4-aminofenilacético |
| EP1753734A1 (en) | 2004-05-05 | 2007-02-21 | Renopharm Ltd. | Nitric oxide donors and uses thereof |
| US20060029565A1 (en) * | 2004-08-09 | 2006-02-09 | The Gillette Company | Self-heating shave foam product |
| EP1844158A4 (en) | 2004-12-06 | 2010-09-08 | Univ Johns Hopkins | BIOMARKERS FOR INFLAMMATORY INTESTINAL DISEASE |
-
2007
- 2007-03-06 ES ES07752538T patent/ES2747259T3/es active Active
- 2007-03-06 MX MX2008011305A patent/MX2008011305A/es unknown
- 2007-03-06 DK DK07752538.4T patent/DK1996710T3/da active
- 2007-03-06 JP JP2008558378A patent/JP5331487B2/ja not_active Expired - Fee Related
- 2007-03-06 WO PCT/US2007/005846 patent/WO2007103448A2/en active Application Filing
- 2007-03-06 CN CN200780008270.5A patent/CN101594885B/zh not_active Expired - Fee Related
- 2007-03-06 BR BRPI0708561-3A patent/BRPI0708561A2/pt not_active IP Right Cessation
- 2007-03-06 PT PT77525384T patent/PT1996710T/pt unknown
- 2007-03-06 CN CN2013101038196A patent/CN103263668A/zh active Pending
- 2007-03-06 CA CA2643364A patent/CA2643364C/en active Active
- 2007-03-06 US US12/224,774 patent/US8987292B2/en active Active
- 2007-03-06 AU AU2007223881A patent/AU2007223881B2/en not_active Ceased
- 2007-03-06 EP EP07752538.4A patent/EP1996710B1/en active Active
- 2007-03-06 KR KR1020087024434A patent/KR101398648B1/ko active IP Right Grant
-
2013
- 2013-06-03 JP JP2013116996A patent/JP2013166794A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013166794A (ja) | 2013-08-29 |
| WO2007103448A3 (en) | 2015-08-06 |
| KR20080110786A (ko) | 2008-12-19 |
| EP1996710A4 (en) | 2016-06-29 |
| CA2643364C (en) | 2017-06-06 |
| EP1996710B1 (en) | 2019-08-14 |
| BRPI0708561A2 (pt) | 2011-06-07 |
| ES2747259T3 (es) | 2020-03-10 |
| KR101398648B1 (ko) | 2014-06-27 |
| CN101594885B (zh) | 2017-07-18 |
| JP2009531308A (ja) | 2009-09-03 |
| WO2007103448A2 (en) | 2007-09-13 |
| US20100048520A1 (en) | 2010-02-25 |
| AU2007223881A1 (en) | 2007-09-13 |
| US8987292B2 (en) | 2015-03-24 |
| CN103263668A (zh) | 2013-08-28 |
| MX2008011305A (es) | 2009-02-10 |
| AU2007223881B2 (en) | 2014-01-09 |
| EP1996710A2 (en) | 2008-12-03 |
| CN101594885A (zh) | 2009-12-02 |
| CA2643364A1 (en) | 2007-09-13 |
| DK1996710T3 (da) | 2019-10-07 |
| JP5331487B2 (ja) | 2013-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1996710T (pt) | Preparação da disfunção anti-rectal de rifaximina. | |
| EP1942028A4 (en) | SEAT | |
| EP1939032A4 (en) | SEAT | |
| EP1942029A4 (en) | SEAT | |
| EP2003357A4 (en) | SEAT | |
| IL194583A0 (en) | Imidazo compounds | |
| EP1944192A4 (en) | SEAT | |
| AU309766S (en) | Tumbler | |
| GB2443427B (en) | Valve | |
| AU311935S (en) | Cup | |
| EP1920581A4 (en) | INTEGRATED CHOICE | |
| ZA200905116B (en) | Macrocyclic compound | |
| GB0605408D0 (en) | Valve | |
| EP2042164A4 (en) | STABILIZED SOLID PREPARATION | |
| HK1093850A2 (en) | Valve | |
| HK1135943A1 (en) | Immobilizer | |
| GB2448461B (en) | Valve | |
| GB2439338B (en) | Valve | |
| HK1129105A1 (en) | Pyrazolo | |
| EP1992256A4 (en) | SEAT | |
| GB0612662D0 (en) | Seat | |
| GB2456271B (en) | Valve | |
| GB0617712D0 (en) | Valve | |
| TWI315539B (en) | Keypad | |
| GB0622348D0 (en) | Retaining means |